Ingredient
Cetyl Tranexamate Mesylate
Cetyl Tranexamate Mesylate is flagged for pregnancy. The concern behind the strongest flag is absorbed into the body.
- Tranexamic Acid Cetyl Ester
- Cetyl Tranexamate HCl
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 1 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Cetyl Tranexamate Mesylate and pregnancy
Caution Advised
- Absorbed into the body
Cetyl Tranexamate Mesylate is a fat-soluble derivative of tranexamic acid, designed for better skin penetration in brightening products. It works by inhibiting melanin production and reducing hyperpigmentation through a mechanism involving plasmin inhibition. The concern during pregnancy stems from its relationship to tranexamic acid. Oral tranexamic acid is pregnancy category B by the FDA, meaning animal studies show no risk but human studies are limited. While the topical cetyl derivative has much lower systemic absorption than oral forms, there's insufficient specific research on topical tranexamic acid derivatives during pregnancy to provide definitive safety assurance. The theoretical concern is that even minimal systemic absorption could affect blood clotting factors, though this hasn't been documented with cosmetic use. Most dermatologists take a conservative approach and suggest postponing use of tranexamic acid derivatives until after pregnancy, particularly because melasma (pregnancy mask) is common during pregnancy and often resolves postpartum. ACOG hasn't issued specific guidance on topical forms, but the lack of comprehensive safety data leads many practitioners to recommend waiting.
Cetyl Tranexamate Mesylate and breastfeeding
Safe to Use
Cetyl Tranexamate Mesylate in topical cosmetics presents minimal concern during breastfeeding. The cetyl ester modification reduces water solubility and increases lipophilicity, which actually limits systemic absorption compared to regular tranexamic acid. The ingredient works primarily in the upper layers of skin. While oral tranexamic acid can be detected in breast milk, the amount absorbed from topical cosmetic use is negligible. Studies on topical tranexamic acid have shown minimal plasma levels, and the cetyl derivative form is designed to remain in skin rather than enter circulation. No adverse effects in breastfed infants from maternal topical use have been reported. The AAD generally considers topical brightening agents with minimal systemic absorption to be compatible with breastfeeding. Many dermatologists feel comfortable recommending topical tranexamic acid derivatives for treating postpartum melasma in breastfeeding mothers, particularly when applied to facial skin away from the breast area.
Cetyl Tranexamate Mesylate and postpartum
Safe to Use
Cetyl Tranexamate Mesylate is particularly beneficial for postpartum women dealing with melasma (pregnancy mask) or other hyperpigmentation that developed during pregnancy. The ingredient inhibits melanin synthesis and can help fade dark patches that often persist after delivery. For women not breastfeeding, there are no safety concerns with using this brightening ingredient. It's highly effective for postpartum pigmentation issues and is often combined with other brightening agents like niacinamide or vitamin C for enhanced results. The postpartum period is an ideal time to address pregnancy-related skin discoloration with active ingredients.
Cetyl Tranexamate Mesylate and trying to conceive
Safe to Use
Cetyl Tranexamate Mesylate in topical cosmetics has no known effects on fertility or conception. The minimal systemic absorption from cosmetic use makes any reproductive impact highly unlikely. Women trying to conceive who want to be extremely conservative with ingredient choices may choose to avoid it due to limited pregnancy-specific data, but the topical form doesn't have documented fertility concerns. Many women continue using brightening products during the TTC period without issue.
Cetyl Tranexamate Mesylate and PCOS
Safe to Use
Cetyl Tranexamate Mesylate can benefit women with PCOS who experience post-inflammatory hyperpigmentation from acne. The ingredient has no hormonal activity and doesn't affect androgen levels or insulin sensitivity. Research suggests tranexamic acid derivatives may have anti-inflammatory properties beyond their brightening effects, which could help reduce the redness and dark marks that often follow acne breakouts in PCOS. It's a safe addition to an acne management routine. Women with PCOS can use this ingredient without concern for hormonal interference. It works well alongside acne treatments to address the pigmentation that commonly occurs after inflammatory acne lesions heal.
Cetyl Tranexamate Mesylate and general use
Safe to Use
Cetyl Tranexamate Mesylate is an effective brightening ingredient that's gained popularity in Asian skincare formulations. It works by inhibiting melanin production through multiple pathways, including blocking plasmin, which activates melanocyte activity. The ingredient is well-tolerated by most skin types and has a low incidence of irritation or sensitivity. It's particularly effective for treating melasma, post-inflammatory hyperpigmentation, and uneven skin tone. Studies show it can be as effective as hydroquinone for some types of pigmentation without the associated risks. The cetyl ester form provides better stability and skin penetration than regular tranexamic acid, making it more effective in cosmetic formulations. It's considered safe for general use with no significant safety concerns documented in the scientific literature or regulatory databases.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Cetyl Tranexamate Mesylate, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store